The Reliever Reliance Test: A New Tool to Address Over-Reliance on Asthma Relievers

Introduction to Asthma and the Role of Reliever Inhalers

Asthma is a chronic respiratory condition that affects millions of people worldwide. For over four decades, short-acting beta2-agonists have been the primary treatment for providing quick relief from asthma symptoms. These inhalers, often referred to as relievers, are commonly prescribed alongside inhaled corticosteroid inhalers that help prevent asthma flare-ups. However, while reliever inhalers offer immediate symptom relief, they do not address the underlying inflammation that causes asthma.

Frequent use of these relievers is linked to poor asthma control, increased risk of severe asthma attacks, and even death. In 2019, the Global Initiative for Asthma revised its guidelines, recommending against using reliever inhalers as the only treatment for asthma symptoms. Instead, the guidelines emphasized the importance of anti-inflammatory treatments, such as corticosteroids, even for managing mild asthma symptoms.

The Problem of Over-Reliance on Reliever Inhalers
Despite updated guidelines, many asthma patients and healthcare providers continue to rely heavily on reliever inhalers due to years of established practice. A study from the SABA Use in Asthma program, which collected data from over one million patients, found that approximately 40 percent of asthma patients used three or more reliever inhalers per year. This level of use is now considered excessive.

Patients often develop an emotional attachment to their reliever inhalers because of the quick relief they provide. Many believe that managing symptoms immediately is more important than preventing future asthma attacks. Some patients also remain unaware that frequent use of reliever inhalers indicates poor asthma control. This mindset, known as reliever over-reliance, involves a strong perceived need for reliever inhalers, anxiety about not having them, and a preference for these inhalers over other treatments.

The Reliever Reliance Test: A Solution to Over-Reliance
The Reliever Reliance Test is a self-assessment tool designed to help asthma patients recognize and address their dependence on reliever inhalers. This tool incorporates the SABA Reliance Questionnaire, which measures patients' perceptions of their need for reliever inhalers. The Reliever Reliance Test provides personalized messages to inform patients about the risks of overusing relievers, encourages reflection on their beliefs, and promotes discussions with healthcare providers about asthma management.

Developed with input from patients, clinicians, and the International Primary Care Respiratory Group, the Reliever Reliance Test is available in over 20 countries in both digital and print formats. It aims to improve clinical practice by addressing misconceptions about asthma treatment and preparing patients for productive conversations with their healthcare providers.

Study Aim and Methodology
A study was conducted to evaluate the effectiveness of the Reliever Reliance Test in Argentina. The study aimed to:

  • Identify patients at risk of reliever over-reliance.
  • Assess changes in patients’ attitudes towards their asthma treatment after completing the test.
  • Determine if the test motivated patients to consult their doctors.
  • Evaluate the acceptability of the test when delivered through a web-based platform.

Participants were recruited through a social media campaign and completed the test online. They were then invited to answer a questionnaire about their experiences with the test.

Key Findings from the Study
Out of 670 participants, 93 completed the Reliever Reliance Test. The study found that 82 percent of participants were at medium to high risk of reliever over-reliance, with 73 percent of these participants using their reliever inhaler three or more times per week.

The majority of participants reported having uncontrolled or partly controlled asthma. Among those with poorly controlled asthma, 75 percent intended to discuss their treatment with a doctor after completing the test.

Impact of the Reliever Reliance Test on Patients
The test significantly influenced patients’ perceptions and intentions.

  • 68 percent of participants felt they depended too much on their reliever inhalers.
  • 72 percent wanted to talk to their doctor about their asthma treatment.
  • 76 percent believed they might not be receiving the best treatment for their asthma.

Additionally, 75 percent of participants found the Reliever Reliance Test helpful, and 72 percent considered it important.

Encouraging Action and Behavior Change
The Reliever Reliance Test was effective in encouraging patients to take action. Among those at medium to high risk of over-reliance:

  • 75 percent intended to make an appointment with their doctor.
  • 28 percent planned to discuss their treatment with a pharmacist.
  • 78 percent wanted to ask their doctor about changing their asthma treatment.
  • 80 percent aimed to seek more information on reliever over-reliance.

Even 41 percent of participants at low risk of over-reliance intended to consult their doctor after completing the test.

Discussion: The Importance of Addressing Over-Reliance
This study highlights the positive impact of the Reliever Reliance Test on asthma patients’ attitudes and intentions. Reducing the use of reliever inhalers is crucial for better asthma management, and this tool offers a promising solution.

The study also showed that patients who have lived with asthma for many years and are often resistant to change can be motivated to seek better treatment options. Even patients on reliever monotherapy, who have no other prescribed asthma treatments, showed high levels of over-reliance.

Healthcare providers often face time constraints and may be hesitant to discuss alternative treatments with patients. The Reliever Reliance Test can help by identifying patients at risk and preparing them for conversations about their treatment.

Limitations and Future Research
While the study provides valuable insights, it has some limitations. The sample size was small, and participants needed digital literacy to take part, which may have excluded some patients. The study also relied on self-reported asthma diagnoses and did not assess whether patients followed through on their intentions to seek help.

Future research should explore the long-term impact of the Reliever Reliance Test on actual behavior change, test its effectiveness in larger and more diverse populations, and assess its use in countries with limited access to alternative asthma treatments.

Conclusion: A Promising Tool for Better Asthma Management
The Reliever Reliance Test is an effective, low-cost tool for identifying and addressing reliever over-reliance among asthma patients. It encourages patients to seek help and consider better treatment options, ultimately aiming to improve asthma management and patient outcomes. As more research is conducted, this tool has the potential to become an essential part of asthma care worldwide.

(this Study was published in the Nature and can be read here 

Comments

Post a Comment

Popular posts from this blog

Understanding Allergic Asthma: The Role of Biomarkers in Predicting Severity

Introduction Allergic asthma is a chronic condition that affects millions of people worldwide. It occurs when allergens trigger inflammation and constriction in the airways, leading to symptoms such as coughing, wheezing, shortness of breath, and chest tightness. While asthma severity varies from person to person, predicting its progression remains a challenge. Recent research has focused on biomarkers—biological indicators found in blood and tissue—that can help doctors assess asthma severity more accurately. A study titled "Assessing Serum and Biopsy Biomarkers for Predicting Allergic Asthma Severity" explores how these biomarkers can improve diagnosis and treatment. In this blog, we’ll break down the findings of this study in simple terms, discussing: What allergic asthma is and why it’s hard to predict The role of biomarkers in understanding asthma Key findings from the study How these findings can help in asthma management. What Is Allergic Asthma? Allergic as...
Read more

New Hope for Seniors with Severe Asthma: How Mepolizumab is Making Breathing Easier

I ntroduction Asthma is a chronic respiratory disease that affects millions of people worldwide. While it is often associated with younger individuals, asthma remains a significant health burden among the elderly . Older adults with severe asthma face unique challenges , including delayed diagnosis, multiple comorbidities, and increased medication dependence. Severe asthma, especially in older patients, is difficult to manage due to age-related immune system changes, lung function decline, and medication side effects . Traditional treatments such as inhaled corticosteroids and bronchodilators may be less effective in elderly patients, making biologic therapies like mepolizumab an attractive alternative. The REDES study is one of the few real-world studies that evaluates the effectiveness and safety of mepolizumab in elderly patients (≥65 years old) with severe eosinophilic asthma . This blog will delve into the study findings, explain mepolizumab’s mechanism of action , explore a...
Read more
Asthma is one of the most common diseases affecting children in the United Kingdom. Many families struggle with managing asthma symptoms, which can often lead to hospital visits, especially during severe attacks. A surprising new study has found that the UK Soft Drinks Industry Levy, introduced to reduce sugar consumption, has also led to a significant drop in childhood hospital admissions for asthma. This article explains the key findings of the study, why they matter, and how reducing sugar intake may benefit children’s health beyond preventing obesity. What Is the UK Soft Drinks Industry Levy? The UK Soft Drinks Industry Levy, often called the sugar tax, was announced in March 2016 and implemented in April 2018. It was designed to reduce the amount of sugar in soft drinks by encouraging manufacturers to reformulate their products. Drinks with more than 5 grams of sugar per 100 milliliters were taxed, with a higher tax for those with more than 8 grams of sugar per 100 milliliters. Dr...
Read more